NTLA smart money
Intellia Therapeutics, INC. (NTLA): 1 insider buy, 4 top funds holding it, 2 ETF changes in the public filings.
Insider buys, 12 months$1.4M
Insider buys
| Filed | Who | Role | Amount | Price |
|---|---|---|---|---|
| 2026-01-07 | Cohen Fred E | Director | $1.4M | $9.35 |
Top 100 funds holding it
| # | Fund | Change | Weight | Value |
|---|---|---|---|---|
| 31 | Affinity Asset Advisors, LLC | BUY | 0.25% | $4M |
| 47 | Casdin Capital, LLC | 0.19% | $4M | |
| 71 | Baker Bros. Advisors LP | TRIM -11% | 0.05% | $10M |
| 72 | Sphera Funds Management LTD. | BUY | 0.16% | $1M |
ETF changes
| ETF | Change | Value | Report |
|---|---|---|---|
| State Street(R) Spdr(R) S&p(R) Biotech ETF | ADD | +$34M | 2026-06-30 |
| Ark Genomic Revolution ETF | TRIM | −$9M | 2026-07-31 |